These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2948271)

  • 1. The cytotoxic T-cell response to Ia antigens: lack of correlation between the level of specific cytotoxicity obtained in primary mixed lymphocyte reaction and the frequency of specific cytotoxic T lymphocyte.
    Beretta A; Langlade Demoyen P; Larsson EL
    Scand J Immunol; 1986 Dec; 24(6):643-51. PubMed ID: 2948271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures.
    Breuning MH; Breur BS; Engelsma MY; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
    Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
    Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.
    Golding H; Singer A
    J Immunol; 1985 Sep; 135(3):1610-5. PubMed ID: 3874902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones.
    Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH
    J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. II. New subtypes of HLA-Bw35.
    Breuning MH; Breur BS; Engelsma MY; Goulmy E; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):90-7. PubMed ID: 6208634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper T cells for cytotoxic T lymphocytes need not be I region restricted.
    Raulet DH; Bevan MJ
    J Exp Med; 1982 Jun; 155(6):1766-84. PubMed ID: 6176668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J
    J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
    Steiner G; Wolff K; Pehamberger H; Stingl G
    J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors.
    Man S; Lechler RI; Batchelor JR; Sharrock CE
    Eur J Immunol; 1990 Apr; 20(4):847-54. PubMed ID: 2112094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR expression on cytotoxic T lymphocytes.
    Ress SR; Strassmann G; Bach FH
    Scand J Immunol; 1985 Nov; 22(5):455-61. PubMed ID: 2934798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency analysis of cyclosporine-sensitive cytotoxic T lymphocyte precursors.
    Heeg K; Deusch K; Solbach W; Bunjes D; Wagner H
    Transplantation; 1984 Nov; 38(5):532-6. PubMed ID: 6238463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L3T4+ cytotoxic T lymphocytes specific for class I H-2 antigens are activated in primary mixed lymphocyte reactions.
    Macphail S; Stutman O
    J Immunol; 1987 Dec; 139(12):4007-15. PubMed ID: 2961804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
    Romani L; Mage MG
    Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytes.
    Kobayashi H; Aso H; Ishida N; Maeda H; Pollard RB; Suzuki F
    Cell Immunol; 1990 Jul; 128(2):589-602. PubMed ID: 2162738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.